+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Europe Human Leukocyte Antigen Testing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product and service, Technology, and End User

  • PDF Icon

    Report

  • 166 Pages
  • September 2022
  • Region: Europe
  • The Insight Partners
  • ID: 5668483
UP TO OFF until Mar 31st 2024
The Europe human leukocyte antigen (HLA) testing market is expected to grow from US$ 188.49 million in 2022 to US$ 287.77 million by 2028; it is estimated to grow at a CAGR of 7.3% from 2022 to 2028.

The broadening scope of applications of HLA testing makes it mandatory before several medical procedures. The histocompatibility laboratory at TriCore Reference Laboratories provides HLA-related testing for transplantation, platelet donation/blood transfusion, forensic testing, parentage testing, disease association, pharmacogenomics, and transfusion medicine applications; among these, HLA testing is commonly used in disease-association testing. Specific HLA alleles are associated with high or low exposure to various diseases. HLA testing can also be used as a complementary method for diagnosing and assessing hereditary risks. The confirmation of the presence or absence of HLA factors associated with each disease or drug-induced adverse reactions can significantly impact therapeutics. Further, blood transfusion is one of the primary procedures that require HLA testing. Several chronic conditions, surgical procedures, and trauma cases require blood transfusion so that patients can survive without any side effects of low blood levels. Conditions including thalassemia, blood cancer, sickle cell anemia, anemia, and surgical and trauma cases lead to blood loss and require a blood transfusion. Thus, the increasing prevalence of chronic diseases magnifies the demand for blood transfusion, thereby propelling the growth of the HLA testing market.

With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe human leukocyte antigen (HLA) testing market at a notable CAGR during the forecast period.

Europe Human Leukocyte Antigen (HLA) Testing Market Segmentation

The Europe human leukocyte antigen (HLA) testing market is segmented into product & services, technology, end user, and country.
  • Based on product & services, the market is segmented into reagents & consumables, instruments, and software & services. In terms of technology, the Europe human leukocyte antigen (HLA) testing market is divided into molecular assay technologies and non-molecular assay technologies. The molecular assay technologies segment is sub segmented into PCR-based molecular assays, sequencing-based molecular assays, and others.
  • Based on end user, the market is divided into independent reference laboratories, hospital and transplant centers, and others.
  • Based on country, the Europe human leukocyte antigen (HLA) testing market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe.

Europe Human Leukocyte Antigen (HLA) Testing Market - Companies Mentioned

THERMO FISHER SCIENTIFIC INC.; CareDx; QIAGEN; Illumina, Inc.; Bio-Rad Laboratories, Inc.; F. HOFFMANN-LA ROCHE LTD.; Takara Bio Inc.; Luminex Corporation; Omixon Inc.; Protrans; and CeGaT GmbH are among the major companies operating in the Europe human leukocyte antigen (HLA) testing market.
Frequently Asked Questions about the European Human Leukocyte Antigen (HLA) Testing Market

What is the estimated value of the European Human Leukocyte Antigen (HLA) Testing Market?

The European Human Leukocyte Antigen (HLA) Testing Market was estimated to be valued at $188.49 Million in 2022.

What is the growth rate of the European Human Leukocyte Antigen (HLA) Testing Market?

The growth rate of the European Human Leukocyte Antigen (HLA) Testing Market is 7.3%, with an estimated value of $287.77 Million by 2028.

What is the forecasted size of the European Human Leukocyte Antigen (HLA) Testing Market?

The European Human Leukocyte Antigen (HLA) Testing Market is estimated to be worth $287.77 Million by 2028.

Who are the key companies in the European Human Leukocyte Antigen (HLA) Testing Market?

Key companies in the European Human Leukocyte Antigen (HLA) Testing Market include THERMO FISHER SCIENTIFIC INC., CareDx, QIAGEN, Illumina, Inc., Bio, Rad Laboratories, Inc., F. HOFFMANN, LA ROCHE LTD., Takara Bio Inc. and Luminex Corporation.

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Human Leukocyte Antigen (HLA) Testing Market - By Product and Services
1.3.2 Europe Human Leukocyte Antigen (HLA) Testing Market - By Technology
1.3.3 Europe Human Leukocyte Antigen (HLA) Testing Market - By End User
1.3.4 Europe Human Leukocyte Antigen (HLA) Testing Market - By Country
2. Europe Human Leukocyte Antigen (HLA) Testing Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Human Leukocyte Antigen (HLA) Testing Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe - PEST Analysis
4.3 Expert Opinion
5. Europe Human Leukocyte Antigen (HLA) Testing Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Number of Plasma Donation and Organ Transplantation Procedures
5.1.2 Expanding Range of Applications of HLA Testing
5.2 Market Restraints
5.2.1 Errors in Accuracy
5.3 Market Opportunities
5.3.1 Rising Government Funding for Organ Donation
5.4 Future Trends
5.4.1 Technological Advancements in Field of Histocompatibility
5.5 Impact Analysis
6. Europe Human Leukocyte Antigen (HLA) Testing Market -Analysis
6.1 Europe Human Leukocyte Antigen (HLA) Testing Market Revenue Forecast and Analysis
7. Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 - by Product and Services
7.1 Overview
7.2 Europe Human Leukocyte Antigen (HLA) Testing Market Share, By Product and Services 2022 & 2028 (%)
7.3 Reagents and Consumables
7.3.1 Overview
7.3.2 Reagents and Consumables: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
7.4 Instruments
7.4.1 Overview
7.4.2 Instruments: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
7.5 Software and Services
7.5.1 Overview
7.5.2 Software and Services : Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
8. Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028- by Technology
8.1 Overview
8.2 Europe Human Leukocyte Antigen (HLA) Testing Market, By Technology 2022 & 2028 (%)
8.3 Molecular Assay Technologies
8.3.1 Overview
8.3.2 Molecular Assay Technologies: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
8.3.3 PCR-Based Molecular Assays
8.3.3.1 Overview
8.3.3.2 PCR-Based Molecular Assays: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
8.3.4 Sequencing-Based Molecular Assays
8.3.4.1 Overview
8.3.4.2 Sequencing-Based Molecular Assays: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
8.3.5 Others
8.3.5.1 Overview
8.3.5.2 Others: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
8.4 Non-Molecular Assay Technologies
8.4.1 Overview
8.4.2 Non-Molecular Assay Technologies: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
9. Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028- by End User
9.1 Overview
9.2 Europe Human Leukocyte Antigen (HLA) Testing Market, By End User 2022 & 2028 (%)
9.3 Independent Reference Laboratories
9.3.1 Overview
9.3.2 Independent Reference Laboratories: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
9.4 Hospital & Transplant Centers
9.4.1 Overview
9.4.2 Hospital & Transplant Centers: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
10. Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028- by Country
10.1 Europe: Europe Human Leukocyte Antigen (HLA) Testing Market
10.1.1 Overview
10.1.2 Europe: Europe Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.1.3 Europe: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
10.1.4 Europe: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.4.1 Europe: Europe Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.5 Europe: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
10.1.6 Europe: Europe Human Leukocyte Antigen (HLA) Testing Market, by Country, 2022 & 2028 (%)
10.1.6.1 Germany: Europe Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.1 Germany: Europe Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.2 Germany: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
10.1.6.1.3 Germany: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.6.1.3.1 Germany: Europe Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.6.1.4 Germany: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
10.1.6.2 France: Europe Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.2.1 France: Europe Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.2.2 France: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
10.1.6.2.3 France: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.6.2.3.1 France: Europe Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.6.2.4 France: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
10.1.6.3 UK: Europe Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.3.1 UK: Europe Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.3.2 UK: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
10.1.6.3.3 UK: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.6.3.3.1 UK: Europe Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.6.3.4 UK: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
10.1.6.4 Italy: Europe Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.4.1 Italy: Europe Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.4.2 Italy: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
10.1.6.4.3 Italy: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.6.4.3.1 Italy: Europe Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.6.4.4 Italy: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
10.1.6.5 Spain: Europe Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.5.1 Spain: Europe Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.5.2 Spain: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
10.1.6.5.3 Spain: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.6.5.3.1 Spain: Europe Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.6.5.4 Spain: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
10.1.6.6 Rest of Europe: Europe Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.6.1 Rest of Europe: Europe Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.6.2 Rest of Europe: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
10.1.6.6.3 Rest of Europe: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.6.6.3.1 Rest of Europe: Europe Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.6.6.4 Rest of Europe: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
11. Europe Human Leukocyte Antigen (HLA) Testing Market - Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Europe Human Leukocyte Antigen (HLA) Testing Market (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 THERMO FISHER SCIENTIFIC INC.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 CareDx
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 QIAGEN
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Illumina, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Bio-Rad Laboratories, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 F. HOFFMANN-LA ROCHE LTD.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Takara Bio Inc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Luminex Corporation
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Omixon Inc.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Protrans
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 CeGaT GmbH
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
13. Appendix
13.1 About the Publisher
13.2 Glossary of Terms

Companies Mentioned

A selection of companies mentioned in this report includes:

  • THERMO FISHER SCIENTIFIC INC.
  • CareDx
  • QIAGEN
  • Illumina, Inc.
  • Bio-Rad Laboratories, Inc.
  • F. HOFFMANN-LA ROCHE LTD.
  • Takara Bio Inc.
  • Luminex Corporation
  • Omixon Inc.
  • Protrans
  • CeGaT GmbH